Company Filing History:
7 out of 37 
3 out of 1,343 
Years Active: 2017-2024
Title: Laurence Bessac: Innovator in Antibody Therapeutics
Introduction
Laurence Bessac is a prominent inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the development of human antibodies for therapeutic applications. With a total of 7 patents to his name, Bessac's work focuses on innovative methods for treating diseases related to cholesterol regulation.
Latest Patents
One of Bessac's latest patents involves the use of human antibodies to PCSK9 for treating specific groups of subjects. This invention outlines methods for addressing diseases where proprotein convertase subtilisin/kexin type 9 (PCSK9) expression or activity has a detrimental impact. The patent details the administration of PCSK9-specific antibodies or their antigen-binding fragments, often in conjunction with an inhibitor of HMG-CoA reductase. Additionally, it includes articles of manufacture that provide essential information on patient groups suitable for treatment and the appropriate dosage regimens. Another significant patent focuses on treating patients with heterozygous familial hypercholesterolemia (heFH) using a pharmaceutical composition that includes a PCSK9 inhibitor, specifically an anti-PCSK9 antibody known as mAb316P. This method is particularly beneficial for patients who do not achieve adequate control with maximum tolerated dose statin therapy.
Career Highlights
Throughout his career, Laurence Bessac has worked with notable companies in the biotechnology sector, including Sanofi Biotechnology and Regeneron Pharmaceuticals, Inc. His experience in these organizations has allowed him to advance his research and contribute to the development of groundbreaking therapies.
Collaborations
Bessac has collaborated with several professionals in his field, including Corinne Hanotin and Umesh Chaudhari. These partnerships have played a crucial role in enhancing the scope and impact of his research.
Conclusion
Laurence Bessac is a distinguished inventor whose work in antibody therapeutics has the potential to transform treatment options for patients with cholesterol-related conditions. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.